Reproductive Psychiatry: Postpartum Depression is Only the Tip of the Iceberg
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field. Articles from the bibliography that are reprinted in this issue are indicated with an asterisk (*).
References
Barone JC, Butler MP, Ross A, et al: A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy. Front Neuroendocrinol 2023; 71:101098
Biggs MA, Upadhyay UD, McCulloch CE, et al: Women’s mental health and well-being 5 years after receiving or being denied an abortion: a prospective, longitudinal cohort study. JAMA Psychiatry 2017; 74:169–178
Bloch M, Schmidt PJ, Danaceau M, et al: Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157:924–930
Bruzelius E, Martins SS: US trends in drug overdose mortality among pregnant and postpartum persons, 2017–2020. JAMA 2022; 328:2159–2161
Carlini SV, Lanza di Scalea T, McNally ST, et al: Management of premenstrual dysphoric disorder: a scoping review. Int J Womens Health 2022; 14:1783–1801
Clark CT, Klein AM, Perel JM, et al: Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry 2013; 170:1240–1247
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. HHS Pub No SMA-18-5054. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2018
Cohen LS, Altshuler LL, Harlow BL, et al: Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295:499–507
Committee opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol 2017; 130:e81–e94
Ecker J, Abuhamad A, Hill W, et al: Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol 2019; 221:B5–B28
Epperson CN, Rubinow DR, Meltzer-Brody S, et al: Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program. J Affect Disord 2023; 320:353–359
Gilden J, Kamperman AM, Munk-Olsen T, et al: Long-term outcomes of postpartum psychosis: a systematic review and meta-analysis. J Clin Psychiatry 2020; 81:19r12906
Guille C, Jones HE, Abuhamad A, et al: Shared decision-making tool for treatment of perinatal opioid use disorder. Psychiatr Res Clin Pract 2019; 1:27–31
Haight SC, Ko JY, Tong VT, et al: Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly Rep 2018; 67:845–849
Huybrechts KF, Palmsten K, Avorn J, et al: Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014; 370:2397–2407
Jairaj C, Seneviratne G, Bergink V, et al: Postpartum psychosis: a proposed treatment algorithm. J Psychopharmacol 2023; 37:960–970
Kravitz HM, Colvin AB, Avis NE, et al: Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN). Menopause 2022; 29:805–815
Molenaar NM, Poels EMP, Robakis T, et al: Management of lithium dosing around delivery: an observational study. Bipolar Disord 2021; 23:49–54
Osborne LM, Payne JL: Mood and Anxiety Disorders: Clinical Updates in Women’s Health Care. Washington, DC, American College of Obstetricians and Gynecologists, 2017. https://www.acog.org/clinical/journals-and-publications/clinical-updates/2017/09/mood-and-anxiety-disorders
Page CE, Soreth B, Metcalf CA, et al: Natural vs. surgical postmenopause and psychological symptoms confound the effect of menopause on executive functioning domains of cognitive experience. Maturitas 2023; 170:64–73
Sachdeva J, Nagle Yang S, Gopalan P, et al: Trauma informed care in the obstetric setting and role of the perinatal psychiatrist: a comprehensive review of the literature. J Acad Consult Liaison Psychiatry 2022; 63:485–496
Screening and diagnosis of mental health conditions during pregnancy and postpartum: ACOG clinical practice guideline No. 4. Obstet Gynecol 2023; 141:1232–1261
Soares CN: Menopause and mood: the role of estrogen in midlife depression and beyond. Psychiatr Clin North Am 2023; 46:463–473
Sprague J, Wisner KL, Bogen DL: Pharmacotherapy for depression and bipolar disorder during lactation: a framework to aid decision making. Semin Perinatol 2020; 44:151224
Straub L, Hernández-Díaz S, Bateman BT, et al: Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study. JAMA Intern Med 2022; 182:522–533
Treatment and management of mental health conditions during pregnancy and postpartum: ACOG clinical practice guideline No. 5. Obstet Gynecol 2023; 141:1262–1288
Trost S, Beauregard J, Chandra G, et al: Pregnancy-related Deaths: Data from Maternal Mortality Review Committees in 36 US States, 2017–2019. Atlanta, GA, Centers for Disease Control and Prevention, US Department of Health and Human Services, 2022. https://www.cdc.gov/reproductivehealth/maternal-mortality/erase-mm/data-mmrc.html
Trost SL, Beauregard JL, Smoots AN, et al: Preventing pregnancy-related mental health deaths: insights from 14 US maternal mortality review committees, 2008–17. Health Aff (Millwood) 2021; 40:1551–1559
US Preventive Services Task Force, Curry SJ, Krist AH, et al: Interventions to prevent perinatal depression: US Preventive Services Task Force recommendation statement. JAMA 2019; 321:580–587
Wagner-Schuman M, Kania A, Barone JC, et al: What’s stopping us? Using GnRH analogs with stable hormone addback in treatment-resistant premenstrual dysphoric disorder: practical guidelines and risk-benefit analysis for long-term therapy. J Clin Psychiatry 2023; 84:22r14614
Wesseloo R, Kamperman AM, Munk-Olsen T, et al: Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry 2016; 173:117–127
Xing L, Xu J, Wei Y, et al: Depression in polycystic ovary syndrome: focusing on pathogenesis and treatment. Front Psychiatry 2022; 13:1001484
Information & Authors
Information
Published In
History
Published in print: Winter 2024
Published online: 16 January 2024
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).